La cadena de opciones muestra datos clave de las opciones de acciones de Schrodinger a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Schrodinger..

Schrodinger (NASDAQ:SDGR) Bolsa, Cadena de Opciones

Schrodinger

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Schrodinger Inc

2024's 'Biggest loses' that could see reversal in 2025

2024's 'Biggest losers' that could see reversal in 2025

2024 Performance Review And Future Strategy

Schrödinger receives regulatory approval for Novartis collaboration

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Schrodinger (SDGR – Research Report) today. The company's shares closed yesterday at $1...

Craig-Hallum Reaffirms Their Buy Rating on Schrodinger (SDGR)

Based on Hunterbrook Media's reporting, Hunterbrook Capital is long Schrodinger (SDGR), the media arm of the firm reported. "Interviews with indust...

Hunterbrook Capital long 'key AI winner' Schrodinger

Moderna spikes as Oracle's Larry Ellison touts AI-driven mRNA vaccines

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Schrodinger (SDGR – Research Report), with a price targe...

Morgan Stanley Reaffirms Their Hold Rating on Schrodinger (SDGR)

Stargate Project's healthcare winners: AI-led biotechs and Metagenomi

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Schrodinger (SDGR – Research Report). The company's shares clo...

ABCL

ABSI

ALGM

AMGN

AMRK

ANSS

ARQT

ARWR

AZTA

BSGM

CBRL

COHU

CRSP

CTKB

DIOD

FIVE

GILD

GNTX

KRYS

KURA

LSCC

MRNA

NTLA

NVSEF

ORCL

POWI

QDEL

RXRX

SDGR

SMMT

SWKS

SYNA

TEVA

TSLA

ULTA

VKTX

VRSN

VRTX

VTRS

Press Releases

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

Schrödinger to Present at Jefferies London Healthcare Conference

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrödinger Reports Third Quarter 2024 Financial Results

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

American Well Corporation Class A Common Stock

American Well

Bullfrog AI Holdings, Inc. - Common Stock

Bullfrog AI Hldgs

CareCloud

Certara

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

MultiPlan Corporation Class A Common Stock

MultiPlan

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Scienture Holdings

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

VSee Health

Waystar Holding

Keybanc

BMO Capital

Morgan Stanley

Leerink Partners

Citigroup

Comments

Schrodinger

Schrodinger (SDGR) Opciones

Schrodinger (NASDAQ:SDGR) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL